163 related articles for article (PubMed ID: 19181417)
1. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer.
Jiang F; Todd NW; Qiu Q; Liu Z; Katz RL; Stass SA
Lung Cancer; 2009 Oct; 66(1):58-63. PubMed ID: 19181417
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
3. A panel of sputum-based genomic marker for early detection of lung cancer.
Jiang F; Todd NW; Li R; Zhang H; Fang H; Stass SA
Cancer Prev Res (Phila); 2010 Dec; 3(12):1571-8. PubMed ID: 20864512
[TBL] [Abstract][Full Text] [Related]
4. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
7. Sputum long non-coding RNA biomarkers for diagnosis of lung cancer.
Gupta C; Su J; Zhan M; Stass SA; Jiang F
Cancer Biomark; 2019; 26(2):219-227. PubMed ID: 31450489
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of quantitative measurement of a proliferation-inducing ligand mRNA in sputum samples from lung cancer patients].
Sun BL; Zhu L; Ding WF; Jing RR; Chu SP; Wang HM
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):182-7. PubMed ID: 19575936
[TBL] [Abstract][Full Text] [Related]
9. Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.
Roa WH; Kim JO; Razzak R; Du H; Guo L; Singh R; Gazala S; Ghosh S; Wong E; Joy AA; Xing JZ; Bedard EL
Clin Invest Med; 2012 Oct; 35(5):E271. PubMed ID: 23043708
[TBL] [Abstract][Full Text] [Related]
10. K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.
Destro A; Bianchi P; Alloisio M; Laghi L; Di Gioia S; Malesci A; Cariboni U; Gribaudi G; Bulfamante G; Marchetti A; Bosari S; Infante M; Ravasi G; Roncalli M
Lung Cancer; 2004 Apr; 44(1):23-32. PubMed ID: 15013580
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
12. The tissue polypeptide antigen serum test in the preoperative evaluation of non-small cell lung cancer. Diagnostic yield and comparison with conventional staging methods.
Buccheri G; Ferrigno D
Chest; 1995 Feb; 107(2):471-6. PubMed ID: 7842779
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.
Shen J; Liao J; Guarnera MA; Fang H; Cai L; Stass SA; Jiang F
J Thorac Oncol; 2014 Jan; 9(1):33-40. PubMed ID: 24305007
[TBL] [Abstract][Full Text] [Related]
15. [18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Wang Q; Huang LL; Yue MG; Qin SL; Wang Y; Nie YX; Zhang CQ; Liang TJ; Zhao YM
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):924-7. PubMed ID: 17533745
[TBL] [Abstract][Full Text] [Related]
16. [Detection of multiple gene mutations in non-small-cell lung cancer by suspension microarray].
Wang D; Ye YK; Su CQ; Rong TH; Guo AY; Yi JH; Liu YJ
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3393-6. PubMed ID: 20223111
[TBL] [Abstract][Full Text] [Related]
17. Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
Kim SJ; Kim YK; Kim IJ; Kim YD; Lee MK
Clin Nucl Med; 2011 Jun; 36(6):434-9. PubMed ID: 21552019
[TBL] [Abstract][Full Text] [Related]
18. Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery.
Kim SH; Lee JH; Lee GJ; Jeong S; Kwak YK; Kim HK; Cho DG; Park YH; Yu M; Yoon SC
Medicine (Baltimore); 2015 Jun; 94(24):e955. PubMed ID: 26091460
[TBL] [Abstract][Full Text] [Related]
19. ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
Yamamoto S; Korn RL; Oklu R; Migdal C; Gotway MB; Weiss GJ; Iafrate AJ; Kim DW; Kuo MD
Radiology; 2014 Aug; 272(2):568-76. PubMed ID: 24885982
[TBL] [Abstract][Full Text] [Related]
20. Altered phosphatidylcholines expression in sputum for diagnosis of non-small cell lung cancer.
Zhang J; Xu J; Lu H; Ding J; Yu D; Li P; Xiong J; Liu X; Chen H; Wei Y
Oncotarget; 2016 Sep; 7(39):63158-63165. PubMed ID: 27542233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
